<p>The World Health Organization(WHO) said its "Executive Group has implemented a temporary pause of the hydroxychloroquine arm within the solidarity trial while the data is reviewed by the data safety monitoring board."</p>

<p><a href="https://www.wionews.com/world/trumps-magic-drug-hydroxychloroquine-may-be-killing-coronavirus-patients-across-the-globe-study-300863">Also Read:&nbsp;Trump's magic drug hydroxychloroquine may be killing coronavirus patients</a>&nbsp;</p>

<p>In a tweet, WHO chief Tedros said that "on Friday, The Lancet had &nbsp;published an observational study on hydroxycholoroquine &amp; chloraquine &amp; its effects on<a href="https://www.wionews.com/world/japan-lifts-coronavirus-emergency-as-cases-decline-300925"> COVID-19</a> patients that have been hospitalised."</p>

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<blockquote class="twitter-tweet">
<p dir="ltr" lang="en">"The Executive Group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity Trial while the data is reviewed by the Data Safety Monitoring Board"-<a href="https://twitter.com/DrTedros?ref_src=twsrc%5Etfw">@DrTedros</a> <a href="https://twitter.com/hashtag/COVID19?src=hash&amp;ref_src=twsrc%5Etfw">#COVID19</a></p>
— World Health Organization (WHO) (@WHO) <a href="https://twitter.com/WHO/status/1264948479480209409?ref_src=twsrc%5Etfw">May 25, 2020</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

<p>"The authors reported that among COVID-19 patients receiving the drug, when used alone or with a macrolide, they estimated a higher mortality rate."</p>

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<blockquote class="twitter-tweet">
<p dir="ltr" lang="en">"The other arms of the trial are continuing.<br />
<br />
This concern relates to the use of hydroxychloroquine and chloraquine in <a href="https://twitter.com/hashtag/COVID19?src=hash&amp;ref_src=twsrc%5Etfw">#COVID19</a>.<br />
<br />
I wish to reiterate that these drugs are accepted as generally safe for use in patients with autoimmune diseases or malaria"-<a href="https://twitter.com/DrTedros?ref_src=twsrc%5Etfw">@DrTedros</a></p>
— World Health Organization (WHO) (@WHO) <a href="https://twitter.com/WHO/status/1264948586778972169?ref_src=twsrc%5Etfw">May 25, 2020</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

<p>US President Trump has repeatedly said that prescription malarial drug could combat coronavirus.</p>

<p>"People are going to have to make up their own mind," the US president had said, adding,"I think it gives you an additional level of safety." The US Food and Drug Administration had earlier warned of potential side effects of the drug if it is used in COVID-19 patients.</p>

<p>"The Executive Group of the solidarity trial, representing 10 of the participating countries, met on Saturday and has agreed to review a comprehensive analysis and critical appraisal of all evidence available globally," Dr Tedros said in a tweet.</p>

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<blockquote class="twitter-tweet">
<p dir="ltr" lang="en">"The review will consider data collected so far in the Solidarity Trial and, in particular robust randomised available data, to adequately evaluate the potential benefits and harms from this drug"-<a href="https://twitter.com/DrTedros?ref_src=twsrc%5Etfw">@DrTedros</a> <a href="https://twitter.com/hashtag/COVID19?src=hash&amp;ref_src=twsrc%5Etfw">#COVID19</a></p>
— World Health Organization (WHO) (@WHO) <a href="https://twitter.com/WHO/status/1264948339499503616?ref_src=twsrc%5Etfw">May 25, 2020</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

<p>"The review will consider data collected so far in the solidarity trial and, in particular robust randomised available data, to adequately evaluate the potential benefits and harms from this drug," the WHO chief added.</p>

<p>"The other arms of the trial are continuing. This concern relates to the use of hydroxychloroquine and chloraquine in COVID-19. I wish to reiterate that these drugs are accepted as generally safe for use in patients with autoimmune diseases or malaria," he added.</p>

<p><br />
&nbsp;</p>


The World Health Organization(WHO) said its "Executive Group has implemented a temporary pause of the hydroxychloroquine arm within the solidarity trial while the data is reviewed by the data safety monitoring board.

The World Health Organization(WHO) said its "Executive Group has implemented a temporary pause of the hydroxychloroquine arm within the solidarity trial while the data is reviewed by the data safety monitoring board." Also Read: Trump's magic drug hydroxychloroquine may be killing coronavirus patients In a tweet, WHO chief Tedros said that "on Friday, The Lancet had published an observational study on hydroxycholoroquine & chloraquine & its effects on COVID-19 patients that have been hospitalised." "The Executive Group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity Trial while the data is reviewed by the Data Safety Monitoring Board"-@DrTedros #COVID19 — World Health Organization (WHO) (@WHO) May 25, 2020 × "The authors reported that among COVID-19 patients receiving the drug, when used alone or with a macrolide, they estimated a higher mortality rate." "The other arms of the trial are continuing. This concern relates to the use of hydroxychloroquine and chloraquine in #COVID19. I wish to reiterate that these drugs are accepted as generally safe for use in patients with autoimmune diseases or malaria"-@DrTedros — World Health Organization (WHO) (@WHO) May 25, 2020 × US President Trump has repeatedly said that prescription malarial drug could combat coronavirus. "People are going to have to make up their own mind," the US president had said, adding,"I think it gives you an additional level of safety." The US Food and Drug Administration had earlier warned of potential side effects of the drug if it is used in COVID-19 patients. "The Executive Group of the solidarity trial, representing 10 of the participating countries, met on Saturday and has agreed to review a comprehensive analysis and critical appraisal of all evidence available globally," Dr Tedros said in a tweet. "The review will consider data collected so far in the Solidarity Trial and, in particular robust randomised available data, to adequately evaluate the potential benefits and harms from this drug"-@DrTedros #COVID19 — World Health Organization (WHO) (@WHO) May 25, 2020 × "The review will consider data collected so far in the solidarity trial and, in particular robust randomised available data, to adequately evaluate the potential benefits and harms from this drug," the WHO chief added. "The other arms of the trial are continuing. This concern relates to the use of hydroxychloroquine and chloraquine in COVID-19. I wish to reiterate that these drugs are accepted as generally safe for use in patients with autoimmune diseases or malaria," he added.

WHO temporarily suspends trial of hydroxychloroquine as COVID-19 treatment

<p>The first of the 50 ventilators, out of 200 being donated by the United States will be arriving soon.&nbsp;</p>

<p>US President Donald Trump in a tweet on May 16 had said: "I am proud to announce that the United States will donate ventilators to our friends in India. We stand with India and @narendramodi during this pandemic. We’re also cooperating on vaccine development. Together we will beat the invisible enemy!"</p>

<p>Both India and US have been helping out each other amid the <a href="https://www.wionews.com/india-news/covid-19-india-provides-aid-to-strategic-partner-tajikistan-299840">COVID-19 </a>crisis. While New Delhi has been sending Hydroxychloroquine to Washington, USAID has announced $5.9 million in funding to combat COVID-19 in India.</p>

<p>"As President Trump recently announced, the US government is planning to donate ventilators to India – another example of our strong partnership during the COVID-19 pandemic", USAID Acting Director Ramona El Hamzaoui said.</p>

<p>New Delhi-Washington partnership has also been expanded to wider Indo-Pacific region.&nbsp;</p>

<p>Indian Foreign Secretary Harsh Vardhan Shringla had engaged with his counterparts from the United States, Australia, Japan, South Korea, New Zealand, and Vietnam in weekly telephonic conversations between March 20 and May 15 to share ideas and best practices.</p>

<p>The practice of weekly tele conversations was initiated by US deputy secretary of state Stephen Biegun.</p>


The first of the 50 ventilators, out of 200 being donated by the United States will be arriving soon. US President Donald Trump in a tweet on May 16 had said: "I am proud to announce that the United States will donate ventilators to our friends in India.

The first of the 50 ventilators, out of 200 being donated by the United States will be arriving soon. US President Donald Trump in a tweet on May 16 had said: "I am proud to announce that the United States will donate ventilators to our friends in India. We stand with India and @narendramodi during this pandemic. We’re also cooperating on vaccine development. Together we will beat the invisible enemy!" Both India and US have been helping out each other amid the COVID-19 crisis. While New Delhi has been sending Hydroxychloroquine to Washington, USAID has announced $5.9 million in funding to combat COVID-19 in India. "As President Trump recently announced, the US government is planning to donate ventilators to India – another example of our strong partnership during the COVID-19 pandemic", USAID Acting Director Ramona El Hamzaoui said. New Delhi-Washington partnership has also been expanded to wider Indo-Pacific region. Indian Foreign Secretary Harsh Vardhan Shringla had engaged with his counterparts from the United States, Australia, Japan, South Korea, New Zealand, and Vietnam in weekly telephonic conversations between March 20 and May 15 to share ideas and best practices. The practice of weekly tele conversations was initiated by US deputy secretary of state Stephen Biegun.

First of 50 ventilators donated by US to India to arrive soon

trump-on-hydroxychloroquine

Trump On Hydroxychloroquine, News on Trump On Hydroxychloroquine, stories on Trump On Hydroxychloroquine, articles on Trump On Hydroxychloroquine, Trump On Hydroxychloroquine stories at Wion, Trump On Hydroxychloroquine news, Trump On Hydroxychloroquine latest news

trump on-hydroxychloroquine

WHO temporarily suspends trial of hydroxychloroquine as COVID-19 treatment

First of 50 ventilators donated by US to India to arrive soon